About CHC Healthcare Group

Was established in 1977

The first subsidiary of CHC Healthcare Group (CHC) was established in 1977, and has nearly 20 subsidiaries working together both in Taiwan and abroad. The group was successfully listed at Taiwan Stock Exchange in October 2012 under the stock code 4164. With over 40 years of expertise in providing comprehensive healthcare management services including sales and leasing of equipment, management consultation, hospital operations and management, CHC is the preferred partner of choice for many medical institutions.

In order to sustain consistent growth in performance, CHC investment holding company is responsible for oversee and manage all the group’s subsidiaries, and with integration of resources, CHC is able to elevate efficiency and performance of the company. Furthermore, by maintain a strong tie with investors through a sounding financial funding structure, CHC ensures maintaining the position of leader in the healthcare industry.

CHC Healthcare Group Headquaders

CHC headquarters is located in Taipei city, Taiwan, but we have established branches in Taichung and Kaohsiung, Guangzhou, Shenyang and Beijing in China, as well as Indonesia. This not only ensures us to provide timely technical support and services for both our domestic and oversea medical institutions, but also share our successful experiences with Mainland China and South East Asia markets. Business scopes of subsidiaries in the Group include radiation oncology, medical imaging, neurology, surgery, ophthalmology and integrated development for hospital researches. We have continuously introduced advanced healthcare equipment and technology into the market, in order to elevate the quality of healthcare services.

Corporate mission:“Connecting your health with our commitment”

With mutual public benefit as our corporate credo, CHC has invested in R&D for radiotherapy platform system for the last few years, and continue to diversify our portfolio by stepping into other sectors such as long-term care and high-tech sterilization technologies. We expect to further promote health and welfare with our core business, ensuring a leading position in the industry of integrated healthcare equipment, technology and service in the Asia-Pacific region.